Research Article
Relationship between Adiponectin Level, Insulin Sensitivity, and Metabolic Syndrome in Type 1 Diabetic Patients
Table 2
Clinical and metabolic characteristics of patients depending on adiponectin concentrations.
| | Variable | Adiponectin < 14.10 g/mL | Adiponectin > 14.10 g/mL | |
| | Age (years) | | | NS | | Gender (m/f) | 31/7 | 16/23 | NS | | Duration of diabetes (years) | 17.5 (1–41) | 25 (2–47) | 0.015 | | Weight (kg) | 83 (52–112) | 68 (54–103) | <0.001 | | BMI (kg/m2) | 26 (18–33) | 24 (20–36) | 0.027 | | Waist circumference (cm) | | | <0.002 | | HbA1c (%) | 7.3 (5.41–11.1) | 7.2 (5.4–12.2) | NS | | SBP (mmHg) | 130 (110–160) | 125 (100–165) | NS | | DBP (mmHg) | 80 (60–110) | 80 (60–100) | NS | | eGDR (mg/kg−1 min−1) | 6.06 (3.79–10.01) | 7.67 (3.78–11.65) | 0.003 | | LDL cholesterol (mmol/L) | 2.79 (1.83–5.20) | 2.74 (1.49–5.32) | NS | | Total HDL cholesterol (mmol/L) | 1.46 (0.83–3.83) | 1.66 (0.78–2.62) | NS | | HDL2 cholesterol (mmol/L) | 0.43 (0.20–2.80) | 0.44 (0.21–1.05) | NS | | HDL3 cholesterol (mmol/L) | 1.06 (0.56–1.53) | 1.23 (0.39–2.28) | 0.011 | | Triglycerides (mmol/L) | | | NS | | AST (U/L) | 24 (15–42) | 22 (13–57) | NS | | ALT (U/L) | 27.5 (12–91) | 22 (12–95) | NS | | GGT (U/L) | 25 (13–92) | 16 (10–59) | 0.042 | | ALP (U/L) | 77 (18–155) | 75 (36–140) | NS | | MS presence (, %) | 17 (44.7%) | 9 (23.1%) | 0.045 |
|
|
ALP: alkaline phosphatase, ALT: alanine aminotransferase, AST: aspartate aminotransferase, GGT: γ-glutamyltransferase, BMI: body mass index, DBP: diastolic blood pressure, HbA1c: glycated hemoglobin, eGDR: estimated glucose disposal rate, and SPB: systolic blood pressure.
|
